This high risk/high reward biotech is at the busness end of proceedings after many years of development. If in 18months or so we are successful in getting FDA approval the returns could be huge. I now am too frightened to trade the stock as I may miss the boat on its potential. I will just have to try very hard and remain disciplined to keep at least a core holding during the coundown to the final outcome.
- Forums
- ASX - By Stock
- IMM
- why nasdaq
why nasdaq, page-17
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $501.1M |
Open | High | Low | Value | Volume |
34.0¢ | 34.5¢ | 33.5¢ | $1.172M | 3.429M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29990 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 174098 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29990 | 0.340 |
1 | 22896 | 0.335 |
10 | 436920 | 0.330 |
5 | 66050 | 0.325 |
7 | 147080 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 174098 | 8 |
0.355 | 124396 | 6 |
0.360 | 135084 | 7 |
0.365 | 158497 | 7 |
0.370 | 398916 | 8 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online